Luhua Lai - Citegraph

Author Info

Name	Affiliation	Papers
LUHUA LAI	Peking Univ, Coll Chem & Mol Engn, Beijing Natl Lab Mol Sci, State Key Lab Struct Chem Unstable & Stable Speci, Beijing 100871, Peoples R China	36
Collaborators	Citations	PageRank
106	369	33.78
Referers	Referees	References
1238	618	208

Search Limit

1001000

Publications (36 rows)

Collaborators (100 rows)

Referers (100 rows)

Referees (100 rows)

Title	Citations	PageRank	Year
Quantitative Analysis of Dynamic Allostery	0	0.34	2022
Multi-Scale High-Resolution Vision Transformer for Semantic Segmentation	0	0.34	2022
Uncovering the Dominant Motion Modes of Allosteric Regulation Improves Allosteric Site Prediction	1	0.35	2022
Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models	0	0.34	2022
Prediction of liquid-liquid phase separating proteins using machine learning	0	0.34	2022
Epharmer: An Integrated And Graphical Software For Pharmacophore-Based Virtual Screening	0	0.34	2021
Discovery of targeted covalent natural products against PLK1 by herb-based screening.	0	0.34	2020
Analysis of protein features and machine learning algorithms for prediction of druggable proteins	0	0.34	2018
Cavityplus: A Web Server For Protein Cavity Detection With Pharmacophore Modelling, Allosteric Site Identification And Covalent Ligand Binding Ability Prediction	0	0.34	2018
Molecular Graph Encoding Convolutional Neural Networks For Automatic Chemical Feature Extraction	0	0.34	2017
Computational Multitarget Drug Design.	2	0.45	2017
Pharmmapper 2017 Update: A Web Server For Potential Drug Target Identification With A Comprehensive Target Pharmacophore Database	3	0.39	2017
Sequence-based prediction of protein protein interaction using a deep-learning algorithm.	21	0.74	2017
Motions of Allosteric and Orthosteric Ligand-Binding Sites in Proteins are Highly Correlated.	0	0.34	2016
Deep Learning for Drug-Induced Liver Injury.	19	0.87	2015
The Center for Quantitative Biology at Peking University	0	0.34	2015
Design of Multitarget Ligands with an Iterative Fragment-Growing Strategy.	3	0.38	2014
iDrug: a web-accessible and interactive drug discovery and design platform.	5	0.42	2014
Ligand Clouds Around Protein Clouds: A Scenario Of Ligand Binding With Intrinsically Disordered Proteins	0	0.34	2013
Sdock: A Global Protein-Protein Docking Program Using Stepwise Force-Field Potentials	2	0.40	2011
LigBuilder 2: a practical de novo drug design approach.	13	0.85	2011
Molecular docking and competitive binding study discovered different binding modes of microsomal prostaglandin E synthase-1 inhibitors.	0	0.34	2011
Identification of Small-Molecule Inhibitors against Human Leukocyte Antigen-Death Receptor 4 (HLA-DR4) Through a Comprehensive Strategy.	0	0.34	2011
Correction to Identification of Small-Molecule Inhibitors against Human Leukocyte Antigen-Death Receptor 4 (HLA-DR4) Through a Comprehensive Strategy.	0	0.34	2011
Binding energy landscape analysis helps to discriminate true hits from high-scoring decoys in virtual screening.	3	0.42	2010
A novel method for enzyme design.	1	0.36	2009
Prediction of potential drug targets based on simple sequence properties.	28	0.85	2007
Computation of octanol-water partition coefficients by guiding an additive model with knowledge.	24	1.25	2007
Dynamic Simulations On The Arachidonic Acid Metabolic Network	15	1.38	2007
Pocket v.2: further developments on receptor-based pharmacophore modeling.	11	0.60	2006
Improving the quality of 3D-QSAR by using flexible-ligand receptor models.	1	0.36	2005
Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase.	5	0.60	2005
Further development and validation of empirical scoring functions for structure-based binding affinity prediction.	165	11.24	2002
Protein ligand docking based on empirical method for binding affinity estimation.	1	0.59	2001
A New Atom-Additive Method For Calculating Partition Coefficients	44	5.75	1997
Rasse: A New Method For Structure-Based Drug Design	2	0.45	1996